Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02708485
What this trial is testing

Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Université de Sherbrooke 15
Large-scale testing (Phase 3)WithdrawnNCT00743743
What this trial is testing

Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Medical College of Wisconsin
Not applicableStudy completedNCT06636760
What this trial is testing

Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery

Who this might be right for
COVID 19
Universitas Indonesia 66
Not applicableStudy completedNCT01636752
What this trial is testing

Effectiveness of Internet-based Depression Treatment

Who this might be right for
Mild to Moderate Depressive Symptoms
University of Luebeck 1,013
Not applicableLooking for participantsNCT07143747
What this trial is testing

PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)

Who this might be right for
Mild Asthma
Dr. Grace Parraga 40
Testing effectiveness (Phase 2)Looking for participantsNCT06471738
What this trial is testing

Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaGrade 1 Follicular LymphomaAnn Arbor Stage III Follicular Lymphoma+3 more
Chinese PLA General Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03887455
What this trial is testing

Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 1,906
Early research (Phase 1)Active Not RecruitingNCT05594225
What this trial is testing

Tele-Rehabilitation to Improve Mild Traumatic Brain Injury Recovery and Reduce Subsequent Injury Risk

Who this might be right for
Brain Concussion
University of Colorado, Denver 88
Large-scale testing (Phase 3)Looking for participantsNCT06488625
What this trial is testing

Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis, Unspecified
University Hospital Schleswig-Holstein 459
Not applicableStudy completedNCT04008784
What this trial is testing

Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period

Who this might be right for
Atopic Dermatitis
Clinical Research Center of the Carolinas 16
Testing effectiveness (Phase 2)UnknownNCT05947747
What this trial is testing

Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS

Who this might be right for
ARDS
Nano24med 90
Testing effectiveness (Phase 2)Ended earlyNCT01025648
What this trial is testing

Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.

Who this might be right for
Asthma
Amphastar Pharmaceuticals, Inc. 9
Early research (Phase 1)Study completedNCT05363215
What this trial is testing

Assess S-217622 in Participants With Renal Impairment and Healthy Participants

Who this might be right for
Renal Impairment
Shionogi 32
Testing effectiveness (Phase 2)Study completedNCT00810147
What this trial is testing

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 209
Testing effectiveness (Phase 2)Study completedNCT06423352
What this trial is testing

Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

Who this might be right for
Mild to Moderate Hypertension
Alnylam Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT00680784
What this trial is testing

HKT-500 in Adult Patients With Ankle Sprain

Who this might be right for
Ankle Sprain
Hisamitsu Pharmaceutical Co., Inc. 260
Early research (Phase 1)Study completedNCT00019838
What this trial is testing

UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05740748
What this trial is testing

Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma

Who this might be right for
Asthma, Allergic
McMaster University 34
Testing effectiveness (Phase 2)Looking for participantsNCT04923126
What this trial is testing

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Who this might be right for
Low-Grade GliomaRecurrent Low-Grade GliomaProgressive Low-Grade Glioma
St. Jude Children's Research Hospital 132
Not applicableNot Yet RecruitingNCT06572878
What this trial is testing

Evaluation of Cognitive and Physical Training on MCI Elders

Who this might be right for
Cognitive ImpairmentMild Cognitive Impairment
Taipei Medical University 144
Next Page